Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Dissection of NTSR2/calcium channel signaling as a non-opioid spinal analgesic mechanism for the treatment of high impact chronic pain

Award Number: R01NS139492
ORGANIZATION: NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 02/01/2025
PERIOD OF PERFORMANCE END DATE: 11/30/2029

Group Awards By:

View Award Description

Dissection of NTSR2/calcium channel signaling as a non-opioid spinal analgesic mechanism for the treatment of high impact chronic pain - Project Summary: Spinal administration of analgesics such as opioids and local anesthetics via an implanted intrathecal drug delivery system have profound efficacy in some of the most severe high impact chronic pain conditions. Despite their profound efficacy, their use is limited primarily because of side effects such as tolerance, psychosis and motor block associated with drugs used in them (opioids, ziconotide, local anesthetics). Novel analgesics that take advantage of spinal pain processing, are safe to use in humans and have minimal motor block and tolerance can be revolutionary in the management of high impact chronic pain conditions. Contulakin-G (CGX) is a snail venom derived peptide that has homology with mammalian neurotensin has been shown to be safe in humans and in a small, pilot Phase1A study demonstrated analgesic effects in patients with spinal cord injury pain, a high impact chronic pain condition. These studies suggested a possibility of a novel, non-opioid, analgesic mechanism that is active in humans. Our preliminary studies in animal models of high impact chronic pain unraveled spinal neurotensin receptor 2 (NTSR2) and subsequent inhibition of voltage-gated calcium channels Cav2.3 and 2.2 as an opioid-independent spinal analgesic mechanism. Importantly, despite profound analgesia, NTSR2 activation was not associated with unwarranted side effects such as rapid tolerance or motor blockade. Despite clear translational relevance of NTSR2-Cav2.3/2.2 pathway, nothing is known about NTSR2 downstream signaling that leads to calcium channel inhibition, particularly so in sensory neurons. Aim 1 will evaluate detailed signaling following NTSR2 activation that leads to calcium channel inhibition in mouse sensory neurons. Aim 2 will assess the anatomical correlation and functional significance of NTSR2-Cav pathway in human sensory neurons and spinal cord. Aim 3 will evaluate in vivo significance of this pathway in models of high impact chronic pain with rigorous independent replication. If successful, proposed studies could unravel the signaling molecules involved in human-tested mechanism for the treatment of high impact chronic pain conditions. Moreover, this information can be utilized for further development of novel analgesics that are biased agonist of or directly engage this signaling pathway.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $537,344 )
2026	2026	THE UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER	5323 HARRY HINES BLVD	DALLAS	TX	75390	DALLAS	USA	Extramural Research Programs in the Neurosciences and Neurological Disorders	000	2	12/9/2025	NON-COMPETING CONTINUATION	$537,344
														Subtotal = $537,344

Issue Date FY: 2025 ( Subtotal = $664,772 )
2025	2025	THE UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER	5323 HARRY HINES BLVD	DALLAS	TX	75390	DALLAS	USA	Extramural Research Programs in the Neurosciences and Neurological Disorders	000	1	2/1/2025	NEW	$664,772
														Subtotal = $664,772

Grand Total All Awards = $1,202,116

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Dissection of NTSR2/calcium channel signaling as a non-opioid spinal analgesic mechanism for the treatment of high impact chronic pain

Award Number: R01NS139492

ORGANIZATION: NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 02/01/2025

PERIOD OF PERFORMANCE END DATE: 11/30/2029

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer